1. Cholangiocarcinoma with an FGFR2 phenotype: outcomes in patients following surgical resection. (2021) Authors: De la Cruz Ku, G.; Buckarma, E.; Truty, M.; Nagorney, D.; Cleary, S.; Kendrick, M.; Grotz, T.; Borad, M.; Graham, R.; Gores, G.; Smoot, R. Journal: HPB Issue: Volume 23(2021)Supplement 2 Page Start: S492 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Hepatic Venous Outflow Obstruction in Polycystic Liver Disease. (2021) Authors: Buckarma, E.; Glasgow, A.; Habermann, E.; Venkatesh, S.; Fidler, J.; Nagorney, D. Journal: HPB Issue: Volume 23(2021)Supplement 1 Page Start: S156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Hippo pathway inhibition increases YAP activity and augments liver regeneration in murine partial hepatectomy. (2021) Authors: Watkins, R.; Buckarma, E.; Starlinger, P.; Gores, G.; Smoot, R. Journal: HPB Issue: Volume 23(2021)Supplement 2 Page Start: S521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The Tyrosine Phosphatase Shp2 Regulates Yapy357 Phosphorylation, And In Vivo Sensitivity To Cytotoxic Chemotherapy In Cholangiocarcinoma. (2020) Authors: Buckarma, E.; Werneburg, N.; Niibe, A.; Gores, G.; Smoot, R. Journal: HPB Issue: Volume 22(2020)Supplement 1 Page Start: S25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Tyrosine Phosphatase Inhibition Increases YAP Activity Augmenting Liver Regeneration in Murine Partial Hepatectomy. (2021) Authors: Buckarma, E.; Pereyra, D.; Starlinger, P.; Smoot, R. Journal: HPB Issue: Volume 23(2021)Supplement 1 Page Start: S159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗